Tamarly Intelligence

Who Holds Alterity Therapeutics Ltd (ATHE)? 22 Institutional Holders, Q2 2026

Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 22 holders, $2 million in total.

Largest holders

The 22 largest by value. Change in shares against Q1 2026.

ManagerSharesValueChange
Twin Lakes Capital Management, LLC139,258$747,815+0%13F
MORGAN STANLEY63,065$338,660+8%13F
GREENLEAF TRUST62,000$332,940+94%13F
HB Wealth Management, LLC58,460$313,930+0%13F
CITADEL ADVISORS LLC37,597$201,896+87%13F
BNP PARIBAS FINANCIAL MARKETS10,239$54,983+50%13F
GAMMA Investing LLC2,309$12,399+24%13F
RHUMBLINE ADVISERS2,009$10,786+2%13F
Providence Capital Advisors, LLC200$1,074New13F
Integrated Wealth Concepts LLC73$392New13F
OSAIC HOLDINGS, INC.68$362+0%13F
Blue Trust, Inc.40$215+0%13F
Farther Finance Advisors, LLC39$205+77%13F
CoreCap Advisors, LLC21$113+0%13F
HRT FINANCIAL LP17,292$92New13F
Steward Partners Investment Advisory, LLC6$32+0%13F
UBS Group AG5$27New13F
ACADIAN ASSET MANAGEMENT LLC1,863$10+0%13F
Cranbrook Wealth Management, LLC1$6New13F
DANSKE BANK A/S1$5+0%13F
Caitong International Asset Management Co., Ltd1$5New13F
CITIGROUP INC1$5New13F

Questions and answers

How many institutions hold Alterity Therapeutics Ltd?
22 managers reported Alterity Therapeutics Ltd on Form 13F for the quarter ended 30 June 2026, against 15 the quarter before.
Who is the largest institutional holder of Alterity Therapeutics Ltd?
Twin Lakes Capital Management, LLC, with 139,258 shares worth $747,815 on its 13F for Q2 2026.
How many institutions bought or sold out of Alterity Therapeutics Ltd in Q2 2026?
7 managers reported a new position and 0 reported none after holding it the quarter before.
See every holder, the full history and an alert when the next 13F filings land; the 7-day trial opens everything.Start the free trial

Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds Alterity Therapeutics Ltd, Q2 2026", https://app.tamarly.ai/holders/alterity-therapeutics, built from SEC EDGAR.

Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.